Bayer Trendlines Ag Innovation Fund.
The Bayer Trendlines Ag Innovation Fund was established in April 2016 as a collaborative partnership between The Trendlines Group and the Bayer Crop Science division of Bayer AG to invest in agricultural technologies. The partnership agreement includes a US$10 million investment from Bayer, managed by Trendlines. Bayer’s decades of experience in agricultural science, innovation and regulatory affairs, alongside Trendlines’ specialization in investing in innovative, early-stage medtech and agrifood technologies, form the base of this strong alliance.
Israel is a hot spot of innovation, and with Trendlines as our partner we can identify novel agtech
solutions to help shape the future of farming.
Bob Reiter, Head of Research and Development, Bayer Crop Science
Nitza Kardish joined the Trendlines management team in June 2011 as CEO of Trendlines Agtech-Mofet. From 2018 through 31 January 2019, Nitza served as CEO of Trendlines Incubators Israel and VP of The Trendlines Group. Since November 2019, Nitza was named CEO of the Trendlines Agrifood Fund.
A plant geneticist, Nitza brings more than 25 years of experience working in senior management positions at life science companies to Trendlines. Prior to joining Trendlines, she served as VP Business Development at the Technion R&D Foundation 2, Ltd. (“Technion Seed”), where she was responsible for the life sciences and cleantech fields.
She previously served as CEO of Clal Life Sciences, an R&D center for emerging life sciences companies; CEO of UroGyn, a start-up that developed minimally invasive surgical tools; and Business Development Manager at Rafael Development Corporation, Ltd.
Nitza earned her doctorate (life sciences) from Tel Aviv University and was a post- doctoral research fellow in the Department of Plant Genetics at the Weizmann Institute of Science. She received an MSc (cum laude) from Tel Aviv University.
Tamar has over seven years’ experience in scouting and deal flow in the life sciences technology industry at ICL Group, as well as application specialist at GE Healthcare and Bio-Rad Laboratories.
Tamar holds a PhD in chemistry and philosophy from Tel Aviv University and an MBA from the Imperial College London.
Bayer Trendlines Ag Innovation Fund.Portfolio